Search for a command to run...
Development of anxiolytic and antidepressant drugs - an historical perspective, M. Sandler anxiety and depression - a clinical profile, P. Tyrer behavioural detection of anxiolytic action, S.E. File a neural system approach to the study of the Amygdala, fear and anxiety, M. Davis behavioural models of depression, R.D. Porsolt and A. Lenegre neurochemical correlates of antidepressant and anxiolytic treatment, D.A. Kendall noradrenergic mechanisms in anxiolytic and antidepressant drug action, D.J. Nutt, et al biochemical measurement of serotonergic neurotransmission in vivo - effect of antidepressant and anxiolytic treatments, T. Sharp the role of GABA in anxiolytic/antidepressant drug action, W. Haefely GABA receptor composition and function in relation to drug action, F.A. Stephenson, et al molecular characterization of D1 dopamine receptors, C.P. Silvia, et al current concepts of serotonin neuronal function and the pathophysiology of depression, D.S. Charney and P.L. Delgado are animal models of mental illness viable?, T.W. Robbins amine mechanisms in anxiety and depression, J.F. W. Deakin new directions in the development of anxiolytic and antidepressant drugs, W.R. Buckett.
Published in: Behavioural Pharmacology
Volume 4, Issue 5, pp. 545???546-545???546